Insiders · GRCE

GRCE insider transactions

Grace Therapeutics Inc. (GRCE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

GRCE insiders

Everyone who has filed a Form 4 or 5 at Grace Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Opaleye Management Inc.10% owner+$169K
• Edward NeugeborenDirector
• A Brian DavisDirector
• Vimal KavuruDirector, 10% owner+$1.25M
• George KottayilOfficer, Director
• Prashant KohliChief Executive Officer, Director+$214K
• R. Loch MacdonaldChief Medical Officer
• Robert J DelAversanoPrincipal Financial Officer
• Amresh KumarVP Program Management
• Carrie D'AndreaVP Clinical Operations
• Donald OldsDirector+$781
• Michael DerbyDirector
• John CananDirector
• Pierre LemieuxOfficer
• Brian D. FordOfficer
• Janelle D'AlviseOfficer, Director

Recent Form 3, 4, and 5 filings for GRCE

• 12h
  Large owner Opaleye Management Inc. bought $33,019 worth of shares (18,442 units at $1.79) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 10d
  Large owner Opaleye Management Inc. bought $158,601 worth of shares (87,801 units at $1.81) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 15d
  Large owner Opaleye Management Inc. bought $8,001 worth of shares (4,256 units at $1.88) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 20d
  Large owner Opaleye Management Inc. bought $136,178 worth of shares (71,065 units at $1.92) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 23d
  Large owner Opaleye Management Inc. bought $18,765 worth of shares (9,292 units at $2.02) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 31d
  Large owner Opaleye Management Inc. bought $3,490 worth of shares (1,694 units at $2.06) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 35d
  Large owner Opaleye Management Inc. bought $16,404 worth of shares (7,849 units at $2.09) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 35d
  Amendment: Large owner Opaleye Management Inc. bought $31,687 worth of shares (15,089 units at $2.10) (SEC Form 4)

  4/A - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 43d
  Large owner Opaleye Management Inc. bought $31,687 worth of shares (15,089 units at $2.10) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 45d
  SEC Form 4 filed by Director Davis A Brian

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 45d
  SEC Form 4 filed by Director Neugeboren Edward

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 45d
  SEC Form 4 filed by Director Kavuru Vimal

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 45d
  SEC Form 4 filed by Director Kottayil George

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 56d
  Large owner Opaleye Management Inc. bought $31,896 worth of shares (15,229 units at $2.09) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 57d
  Chief Executive Officer Kohli Prashant bought $214,000 worth of shares (100,000 units at $2.14), increasing direct ownership by 468% to 121,357 units (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 65d
  SEC Form 4 filed by Chief Medical Officer Macdonald R. Loch

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 65d
  SEC Form 4 filed by Principal Financial Officer Delaversano Robert J

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 65d
  SEC Form 4 filed by VP Program Management Kumar Amresh

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 65d
  SEC Form 4 filed by Chief Executive Officer Kohli Prashant

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 79d
  Large owner Opaleye Management Inc. bought $24,206 worth of shares (11,608 units at $2.09) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 297d
  SEC Form 4 filed by Director Kavuru Vimal

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 297d
  SEC Form 4 filed by Director Neugeboren Edward

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 297d
  SEC Form 4 filed by Director Davis A Brian

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 297d
  SEC Form 4 filed by Director Kottayil George

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 541d
  SEC Form 4 filed by Director Kottayil George

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 541d
  SEC Form 4 filed by Director Davis A Brian

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 541d
  SEC Form 4 filed by Director Kavuru Vimal

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 541d
  SEC Form 4 filed by Director Neugeboren Edward

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 568d
  SEC Form 4 filed by Chief Medical Officer Macdonald R. Loch

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 568d
  SEC Form 4 filed by VP Program Management Kumar Amresh

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 568d
  SEC Form 4 filed by VP Clinical Operations D'Andrea Carrie

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 568d
  SEC Form 4 filed by Principal Financial Officer Delaversano Robert J

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 568d
  SEC Form 4 filed by Chief Executive Officer Kohli Prashant

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)